Evaluation of the Impact of Tocilizumab Use in Recipients of CAR T Cells for Non-Hodgkin Lymphoma

被引：0

作者：

Cassanello, Giulio ^{[1
,2
]}

Luttwak, Efrat ^{[3
]}

Devlin, Sean M. ^{[4
]}

De Abia, Alejandro Luna ^{[1
]}

Corona, Magdalena ^{[1
]}

Landego, Ivan ^{[1
]}

Parascondola, Allison ^{[1
]}

Saldia, Amethyst ^{[1
]}

Alarcon Tomas, Ana ^{[1
,5
]}

Dahi, Parastoo B. ^{[1
]}

Lin, Richard J. ^{[1
]}

Palomba, M. Lia ^{[3
]}

Park, Jae H. ^{[6
]}

Salles, Gilles ^{[3
]}

Perales, Miguel-Angel ^{[1
]}

Scordo, Michael ^{[1
]}

Shouval, Roni ^{[1
]}

Shah, Gunjan L. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[2] Univ Milan, Milan, Italy

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY USA

[5] Hosp Gen Univ Gregorio Maranon, Div Hematol & Hemotherapy, Madrid, Spain

[6] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190500

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] The therapeutic use of rituximab in non-Hodgkin's lymphoma
Marcus, Robert
Hagenbeek, Anton
EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 : 5 - 14
[42] Hair dye use and non-Hodgkin lymphoma -: Reply
Takkouche, B
Montes-Martínez, A
Etminan, M
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (10): : 1205 - 1205
[43] Expanded use of rituximab in the management of non-Hodgkin lymphoma
Eichenauer, Dennis A.
Engert, Andreas
Schulz, Holger
ONCOTARGETS AND THERAPY, 2009, 2 : 189 - 197
[44] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Bei Hu
Ryan Jacobs
Nilanjan Ghosh
Current Hematologic Malignancy Reports, 2018, 13 : 543 - 554
[45] The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Hirayama, Alexandre V.
Gauthier, Jordan
Hay, Kevin A.
Voutsinas, Jenna M.
Wu, Qian
Gooley, Ted
Li, Daniel
Cherian, Sindhu
Chen, Xueyan
Pender, Barbara S.
Hawkins, Reed M.
Vakil, Aesha
Steinmetz, Rachel N.
Acharya, Utkarsh H.
Cassaday, Ryan D.
Chapuis, Aude G.
Dhawale, Tejaswini M.
Hendrie, Paul C.
Kiem, Hans-Peter
Lynch, Ryan C.
Ramos, Jorge
Shadman, Mazyar
Till, Brian G.
Riddell, Stanley R.
Maloney, David G.
Turtle, Cameron J.
BLOOD, 2019, 133 (17) : 1876 - 1887
[46] POSTMENOPAUSAL HORMONE USE AND RISK OF NON-HODGKIN LYMPHOMA
Teras, L. R.
Patel, A. V.
Hildebrand, J.
Gapstur, S. M.
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S250 - S250
[47] Medication use and risk of non-Hodgkin's lymphoma
Chang, ET
Smedby, KE
Hjalgrim, H
Schöllkopf, C
Porwit-MacDonald, A
Sundström, C
Tani, E
d'Amore, F
Melbye, M
Adami, HO
Glimelius, B
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (10) : 965 - 974
[48] Residential herbicide use and risk of non-Hodgkin lymphoma
Hartge, P
Colt, JS
Severson, RK
Cerhan, JR
Cozen, W
Camann, D
Zahm, SH
Davis, S
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 934 - 937
[49] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Hu, Bei
Jacobs, Ryan
Ghosh, Nilanjan
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 543 - 554
[50] An evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma
Huebel, Kai
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (16) : 1829 - 1834

← 1 2 3 4 5 →